Previous Statements by MDT
» Medtronic's CEO Discusses Q2 2012 Results - Earnings Call Transcript
» Medtronic, Inc. Shareholder/Analyst Call
» Medtronic's CEO Discusses Q1 2012 Results - Earnings Call Transcript
State-backed Chinese pharmaceutical companies have shown interest.
Medtronic is still working to fill back orders.
The Trump administration's creep towards scrapping certain tax regulations could revive inversion deals that have allowed U.S. companies to avoid billions of dollars in taxes.